Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Po-Ku Chen, Shiow-Jiuan Wey & Der-Yuan Chen. (2022) Interleukin-18: a biomarker with therapeutic potential in adult-onset Still’s disease. Expert Review of Clinical Immunology 18:8, pages 823-833.
Read now
Read now
Articles from other publishers (14)
Mengyuan Duan, Min Shen, Yongting Zhou, Yi He, Zehao Guo, Caiying Ye, Juan Li & Lei Zhu. (2022) AIM2 and NLRC4-driven inflammasome activation in adult-onset Still’s disease and the preliminary therapeutic effect exploration of carboxyamidotriazole. Clinical Rheumatology 42:6, pages 1635-1643.
Crossref
Crossref
Jinchao Jia, Mengyan Wang, Jianfen Meng, Yuning Ma, Yang Wang, Naijun Miao, Jialin Teng, Dehao Zhu, Hui Shi, Yue Sun, Honglei Liu, Xiaobing Cheng, Yutong Su, Junna Ye, Huihui Chi, Tingting Liu, Zhuochao Zhou, Liyan Wan, Xia Chen, Fan Wang, Hao Zhang, Jingjing Ben, Jing Wang, Chengde Yang & Qiongyi Hu. (2022) Ferritin triggers neutrophil extracellular trap-mediated cytokine storm through Msr1 contributing to adult-onset Still’s disease pathogenesis. Nature Communications 13:1.
Crossref
Crossref
José Inciarte-Mundo, Beatriz Frade-Sosa & Raimon Sanmartí. (2022) From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis. Frontiers in Immunology 13.
Crossref
Crossref
Beatrice Maranini, Giovanni Ciancio & Marcello Govoni. (2021) Adult-Onset Still’s Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms. International Journal of Molecular Sciences 22:24, pages 13320.
Crossref
Crossref
Piero Ruscitti, Onorina Berardicurti, Roberto Giacomelli & Paola Cipriani. (2021) The clinical heterogeneity of adult onset Still’s disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients. Seminars in Immunology 58, pages 101632.
Crossref
Crossref
Khetam Ghannam, Jan Zernicke, Claudia Kedor, Joachim Listing, Gerd-R. Burmester, Dirk Foell & Eugen Feist. (2021) Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still’s Disease and Active Articular Manifestation Responding to Canakinumab. Journal of Clinical Medicine 10:19, pages 4400.
Crossref
Crossref
Yuning Ma, Jianfen Meng, Jinchao Jia, Mengyan Wang, Jialin Teng, Dehao Zhu, Chengde Yang & Qiongyi Hu. (2021) Current and emerging biological therapy in adult-onset Still’s disease. Rheumatology 60:9, pages 3986-4000.
Crossref
Crossref
Hideto Nagai, Yohei Kirino, Hiroto Nakano, Yosuke Kunishita, Riko Henmi, Ann Marie Szymanski, Ryusuke Yoshimi, Michael J Ombrello & Hideaki Nakajima. (2021) Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease. Rheumatology 60:8, pages 3888-3895.
Crossref
Crossref
Po-Ku Chen & Der-Yuan Chen. (2021) An Update on the Pathogenic Role of Macrophages in Adult-Onset Still’s Disease and Its Implication in Clinical Manifestations and Novel Therapeutics. Journal of Immunology Research 2021, pages 1-11.
Crossref
Crossref
Mengyan Wang, Mengru Liu, Jinchao Jia, Hui Shi, Jialin Teng, Honglei Liu, Yue Sun, Xiaobing Cheng, Junna Ye, Yutong Su, Huihui Chi, Tingting Liu, Zhihong Wang, Liyan Wan, Jianfen Meng, Yuning Ma, Chengde Yang & Qiongyi Hu. (2021) Association of the Leukocyte Immunoglobulin‐like Receptor A3 Gene With Neutrophil Activation and Disease Susceptibility in Adult‐Onset Still’s Disease. Arthritis & Rheumatology 73:6, pages 1033-1043.
Crossref
Crossref
Jinchao Jia, Luyu Yang, Zhujun Cao, Mengyan Wang, Yuning Ma, Xiong Ma, Qiaoyan Liu, Jialin Teng, Hui Shi, Honglei Liu, Xiaobing Cheng, Junna Ye, Yutong Su, Yue Sun, Huihui Chi, Tingting Liu, Zhihong Wang, Liyan Wan, Chengde Yang & Qiongyi Hu. (2021) Neutrophil-derived lipocalin-2 in adult-onset Still’s disease: a novel biomarker of disease activity and liver damage. Rheumatology 60:1, pages 304-315.
Crossref
Crossref
Ju-Yang Jung, Ji-Won Kim, Chang-Hee Suh & Hyoun-Ah Kim. (2020) Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease. Frontiers in Immunology 11.
Crossref
Crossref
Julia Krämer, Tanja Krömer-Olbrisch, Heinz-Jürgen Lakomek, Peter D. Schellinger, Dirk Foell, Sven G. Meuth & Vera Straeten. (2020) Case Report: Adult Still’s Disease in an Alemtuzumab-Treated Multiple Sclerosis Patient. Frontiers in Immunology 11.
Crossref
Crossref
Meng-Yan Wang, Jin-Chao Jia, Cheng-De Yang & Qiong-Yi Hu. (2019) Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review. Chinese Medical Journal 132:23, pages 2856-2864.
Crossref
Crossref